Clinical Trial: Safety and Preliminary Efficacy of Hibernation-Like Therapy (Chlorpromazine and Promethazine) in Patients With Acute Ischemic Stroke (AIS) Eligible for Reperfusion Therapy.

U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364344) titled 'Safety and Preliminary Efficacy of Hibernation-Like Therapy (Chlorpromazine and Promethazine) in Patients With Acute Ischemic Stroke (AIS) Eligible for Reperfusion Therapy.' on Jan. 04.

Brief Summary: This is a single-center, dose-escalation and dose-expansion Phase I study designed to evaluate the safety of hibernation-like therapy (Chlorpromazine and Promethazine, C+P) and observe improvements in infarct volume in patients with AIS eligible for reperfusion therapy.

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: Hibernation-like Therapy (Chlorpromazine and Prometha...